Yufei Qin - Global Medical Director
| GMRE Stock | USD 8.11 0.02 0.25% |
Director
Ms. Qin Yufei is Director of the Company. Ms. Qin currently serves as the Director Assistant of the Administrative and Secretary Department of Henan Zensun Real Estate Co. Ltd a position she has held since June 2009. Ms. Qin is responsible for creating and executing Zensuns property development strategy. In this role she participates in Zensuns financing activities and negotiates Zensuns international business activities including acquisitions of foreign businesses hotel management and crossborder private equity issues. Ms. Qin also serves as a relationship manager for Zensun and its local government and business authorities. From October 2005 to October 2006 Ms. Qin served as a professional journalist for Henan Television and from October 2003 to October 2005 served as senior lecturer and sales training manager for New China Life Insurance Co since 2015.
| Age | 33 |
| Tenure | 9 years |
| Address | 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814 |
| Phone | 202 524 6851 |
| Web | https://www.globalmedicalreit.com |
Global Medical Management Efficiency
The company has return on total asset (ROA) of 0.0178 % which means that it generated a profit of $0.0178 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0346 %, meaning that it created $0.0346 on every $100 dollars invested by stockholders. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 71.9 M, whereas Total Current Assets are forecasted to decline to about 13.4 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ronald Geary | Sabra Healthcare REIT | 70 | |
| Spencer Plumb | CareTrust REIT | 43 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Matthew Lustig | Ventas Inc | 59 | |
| Milton Walters | Sabra Healthcare REIT | 75 | |
| Dan Wilford | Healthcare Realty Trust | 74 | |
| Thomas Franke | Omega Healthcare Investors | 84 | |
| Allen Barbieri | CareTrust REIT | 59 | |
| Lynne Katzmann | Sabra Healthcare REIT | 61 | |
| Glenn Rufrano | Ventas Inc | 67 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Robert Webb | National Health Investors | 76 | |
| Craig Bernfield | Omega Healthcare Investors | 56 | |
| Norman Bobins | Omega Healthcare Investors | 75 | |
| Errol Biggs | Healthcare Realty Trust | 73 | |
| Dana Hambly | National Health Investors | N/A | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Alfred Lumsdaine | Community Healthcare Trust | 50 | |
| Colleen Schaller | National Health Investors | N/A | |
| Diana Laing | CareTrust REIT | 63 | |
Management Performance
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0178 |
Global Medical REIT Leadership Team
Elected by the shareholders, the Global Medical's board of directors comprises two types of representatives: Global Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Medical's management team and ensure that shareholders' interests are well served. Global Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew Cypher, Independent Director | ||
| Robert CPA, CFO Treasurer | ||
| Yufei Qin, Director | ||
| Robert Kiernan, Chief Financial Officer, Treasurer | ||
| Jingguo Zhang, Director | ||
| Roscoe Moore, Independent Director | ||
| Ronald Marston, Independent Director | ||
| Tong Chan, Director | ||
| Mark Kennedy, Senior Vice President - Business Development | ||
| Paula Crowley, Independent Director | ||
| Mary Jensen, Investor Professional | ||
| Conn Flanigan, General Counsel, Secretary and Director | ||
| Donald McClure, CFO | ||
| Allen Webb, Senior Vice President - SEC Reporting and Technical Accounting | ||
| Henry Cole, Lead Independent Director | ||
| Yanping Huang, Director | ||
| Huiqi Zhang, Director | ||
| Jamie Barber, General Counsel, Secretary | ||
| Jing Zhang, Director | ||
| David Young, CEO and Director | ||
| Jeffery Busch, President Chairman | ||
| Lori Wittman, Independent Director | ||
| Danica Holley, Chief Operating Officer | ||
| Alfonzo Leon, Chief Investment Officer | ||
| Fai Chan, Director | ||
| Jeffrey Busch, Chairman of the Board , President , Chief Executive Officer | ||
| Kurt Harrington, Director |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0178 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 1.22 B | ||||
| Shares Outstanding | 65.59 M | ||||
| Shares Owned By Insiders | 5.75 % | ||||
| Shares Owned By Institutions | 58.85 % | ||||
| Number Of Shares Shorted | 1.32 M | ||||
| Price To Earning | 39.78 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Global Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Global Medical's short interest history, or implied volatility extrapolated from Global Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Global Stock analysis
When running Global Medical's price analysis, check to measure Global Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Medical is operating at the current time. Most of Global Medical's value examination focuses on studying past and present price action to predict the probability of Global Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Medical's price. Additionally, you may evaluate how the addition of Global Medical to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Global Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 0.21 | Earnings Share 0.23 | Revenue Per Share 2.152 | Quarterly Revenue Growth (0.09) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.